-
Something wrong with this record ?
Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis
J. Fucikova, E. Becht, K. Iribarren, J. Goc, R. Remark, D. Damotte, M. Alifano, P. Devi, J. Biton, C. Germain, A. Lupo, WH. Fridman, MC. Dieu-Nosjean, G. Kroemer, C. Sautès-Fridman, I. Cremer,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT14533
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Free Medical Journals
from 1941 to 1 year ago
Freely Accessible Science Journals
from 1941 to 1 year ago
Open Access Digital Library
from 1941-01-01
Open Access Digital Library
from 1941-01-01
- MeSH
- Calreticulin metabolism MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Lung Neoplasms metabolism mortality MeSH
- Carcinoma, Non-Small-Cell Lung metabolism mortality MeSH
- Prognosis MeSH
- Prospective Studies MeSH
- Retrospective Studies MeSH
- T-Lymphocyte Subsets metabolism MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
A high density of tumor-infiltrating mature dendritic cells (DC) and CD8(+) T cells correlates with a positive prognosis in a majority of human cancers. The recruitment of activated lymphocytes to the tumor microenvironment, primed to recognize tumor-associated antigens, can occur in response to immunogenic cell death (ICD) of tumor cells. ICD is characterized by the preapoptotic translocation of calreticulin (CRT) from the endoplasmic reticulum (ER) to the cell surface as a result of an ER stress response accompanied by the phosphorylation of eukaryotic initiation factor 2α (eIF2α). We conducted a retrospective study on two independent cohorts of patients with non-small cell lung cancer (NSCLC) to investigate the prognostic potential of CRT. We report that the level of CRT expression on tumor cells, which correlated with eIF2α phosphorylation, positively influenced the clinical outcome of NSCLC. High CRT expression on tumor cells was associated with a higher density of infiltrating mature DC and effector memory T-cell subsets, suggesting that CRT triggers the activation of adaptive immune responses in the tumor microenvironment. Accordingly, patients with elevated CRT expression and dense intratumoral infiltration by DC or CD8(+) T lymphocytes had the best prognosis. We conclude that CRT expression constitutes a new powerful prognostic biomarker that reflects enhanced local antitumor immune responses in the lung.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014120
- 003
- CZ-PrNML
- 005
- 20191115111635.0
- 007
- ta
- 008
- 170413s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1158/0008-5472.CAN-15-1142 $2 doi
- 035 __
- $a (PubMed)26842877
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Fučíková, Jitka, $u Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic. Sotio, Prague, Czech Republic. $d 1983- $7 xx0116819
- 245 10
- $a Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis / $c J. Fucikova, E. Becht, K. Iribarren, J. Goc, R. Remark, D. Damotte, M. Alifano, P. Devi, J. Biton, C. Germain, A. Lupo, WH. Fridman, MC. Dieu-Nosjean, G. Kroemer, C. Sautès-Fridman, I. Cremer,
- 520 9_
- $a A high density of tumor-infiltrating mature dendritic cells (DC) and CD8(+) T cells correlates with a positive prognosis in a majority of human cancers. The recruitment of activated lymphocytes to the tumor microenvironment, primed to recognize tumor-associated antigens, can occur in response to immunogenic cell death (ICD) of tumor cells. ICD is characterized by the preapoptotic translocation of calreticulin (CRT) from the endoplasmic reticulum (ER) to the cell surface as a result of an ER stress response accompanied by the phosphorylation of eukaryotic initiation factor 2α (eIF2α). We conducted a retrospective study on two independent cohorts of patients with non-small cell lung cancer (NSCLC) to investigate the prognostic potential of CRT. We report that the level of CRT expression on tumor cells, which correlated with eIF2α phosphorylation, positively influenced the clinical outcome of NSCLC. High CRT expression on tumor cells was associated with a higher density of infiltrating mature DC and effector memory T-cell subsets, suggesting that CRT triggers the activation of adaptive immune responses in the tumor microenvironment. Accordingly, patients with elevated CRT expression and dense intratumoral infiltration by DC or CD8(+) T lymphocytes had the best prognosis. We conclude that CRT expression constitutes a new powerful prognostic biomarker that reflects enhanced local antitumor immune responses in the lung.
- 650 _2
- $a kalretikulin $x metabolismus $7 D037282
- 650 _2
- $a nemalobuněčný karcinom plic $x metabolismus $x mortalita $7 D002289
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory plic $x metabolismus $x mortalita $7 D008175
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a T-lymfocyty - podskupiny $x metabolismus $7 D016176
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Becht, Etienne $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
- 700 1_
- $a Iribarren, Kristina $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
- 700 1_
- $a Goc, Jeremy $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
- 700 1_
- $a Remark, Romain $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
- 700 1_
- $a Damotte, Diane $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France. Service d'Anatomie-Pathologique, Hôpital Hotel Dieu, AP-HP, Paris, France.
- 700 1_
- $a Alifano, Marco $u Service de Chirurgie Thoracique, Hôpital Cochin, AP-HP, Paris, France. $7 gn_A_00004243
- 700 1_
- $a Devi, Priyanka $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
- 700 1_
- $a Biton, Jerome $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
- 700 1_
- $a Germain, Claire $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
- 700 1_
- $a Lupo, Audrey $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France. Service d'Anatomie-Pathologique, Hôpital Hotel Dieu, AP-HP, Paris, France.
- 700 1_
- $a Fridman, Wolf Herve $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
- 700 1_
- $a Dieu-Nosjean, Marie-Caroline $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
- 700 1_
- $a Kroemer, Guido $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France. Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Sautès-Fridman, Catherine $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
- 700 1_
- $a Cremer, Isabelle $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France. isabelle.cremer@crc.jussieu.fr.
- 773 0_
- $w MED00009437 $t Cancer research $x 1538-7445 $g Roč. 76, č. 7 (2016), s. 1746-1756
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26842877 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20191115111914 $b ABA008
- 999 __
- $a ok $b bmc $g 1200585 $s 974898
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 76 $c 7 $d 1746-1756 $e 20160203 $i 1538-7445 $m Cancer research $n Cancer Res $x MED00009437
- GRA __
- $a NT14533 $p MZ0
- LZP __
- $a Pubmed-20170413